Clinical targeting of the TNF and TNFR superfamilies
M Croft, CA Benedict, CF Ware - Nature reviews Drug discovery, 2013 - nature.com
Inhibitors of tumour necrosis factor (TNF) are among the most successful protein-based
drugs (biologics) and have proven to be clinically efficacious at reducing inflammation …
drugs (biologics) and have proven to be clinically efficacious at reducing inflammation …
A guiding map for inflammation
MG Netea, F Balkwill, M Chonchol, F Cominelli… - Nature …, 2017 - nature.com
Biologists, physicians and immunologists have contributed to the understanding of the
cellular participants and biological pathways involved in inflammation. Here, we provide a …
cellular participants and biological pathways involved in inflammation. Here, we provide a …
Strategies to therapeutically modulate cytokine action
WJ Leonard, JX Lin - Nature Reviews Drug Discovery, 2023 - nature.com
Cytokines are secreted or membrane-presented molecules that mediate broad cellular
functions, including development, differentiation, growth and survival. Accordingly, the …
functions, including development, differentiation, growth and survival. Accordingly, the …
Next-generation cytokines for cancer immunotherapy
Most studies focus on the first and second signals of T cell activation. However, the roles of
cytokines in immunotherapy are not fully understood, and cytokines have not been widely …
cytokines in immunotherapy are not fully understood, and cytokines have not been widely …
Pharmacological strategies to resolve acute inflammation
Highlights•Inflammation is a physiological process which restores tissue homeostasis.•
Unresolved inflammation can contribute to the pathogenesis of chronic inflammatory …
Unresolved inflammation can contribute to the pathogenesis of chronic inflammatory …
Inflammatory resolution: new opportunities for drug discovery
Abstract Treatment of inflammatory diseases today is largely based on interrupting the
synthesis or action of mediators that drive the host's response to injury. Non-steroidal anti …
synthesis or action of mediators that drive the host's response to injury. Non-steroidal anti …
Therapeutic uses of anti-interleukin-6 receptor antibody
S Kang, T Tanaka, T Kishimoto - International immunology, 2015 - academic.oup.com
Cytokine-targeted therapy has generated a paradigm shift in the treatment of several
immune-mediated diseases. Interleukin-6 (IL-6), which was initially identified as B-cell …
immune-mediated diseases. Interleukin-6 (IL-6), which was initially identified as B-cell …
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
SA Jones, BJ Jenkins - Nature reviews immunology, 2018 - nature.com
The IL-6 family of cytokines consists of IL-6, IL-11, IL-27, IL-31, oncostatin M (OSM),
leukaemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), cardiotrophin 1 (CT-1) …
leukaemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), cardiotrophin 1 (CT-1) …
Anti-inflammatory therapy in chronic disease: challenges and opportunities
A number of widespread and devastating chronic diseases, including atherosclerosis, type 2
diabetes, and Alzheimer's disease, have a pathophysiologically important inflammatory …
diabetes, and Alzheimer's disease, have a pathophysiologically important inflammatory …
Resolution of inflammation: mechanisms and opportunity for drug development
Inflammation is a beneficial host reaction to tissue damage and has the essential primary
purpose of restoring tissue homeostasis. Inflammation plays a major role in containing and …
purpose of restoring tissue homeostasis. Inflammation plays a major role in containing and …